ImmunityBio, Inc.
IBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$414 | -$584 | -$417 | -$347 |
| Dep. & Amort. | $18 | $19 | $35 | $14 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $34 | $49 | $40 | $57 |
| Change in WC | -$19 | $4 | -$16 | -$15 |
| Other Non-Cash | -$10 | $145 | $20 | $16 |
| Operating Cash Flow | -$391 | -$367 | -$338 | -$274 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$31 | -$78 | -$34 |
| Net Acquisitions | -$1 | $0 | $0 | $0 |
| Inv. Purchases | -$140 | -$10 | $0 | $0 |
| Inv. Sales/Matur. | $137 | $10 | $0 | $0 |
| Other Inv. Act. | -$1 | $0 | $105 | -$51 |
| Investing Cash Flow | -$12 | -$30 | $27 | -$85 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $97 | $259 | $174 | $339 |
| Stock Issued | $111 | $110 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$1 | -$4 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $73 | $190 | $60 | $171 |
| Financing Cash Flow | $282 | $558 | $234 | $505 |
| Forex Effect | -$0 | -$0 | $0 | $0 |
| Net Chg. in Cash | -$122 | $161 | -$76 | $146 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $266 | $105 | $181 | $35 |
| End Cash | $144 | $266 | $105 | $181 |
| Free Cash Flow | -$398 | -$397 | -$416 | -$308 |